Cancer as a Mitochondrial Metabolic Disease: Thomas Seyfried

On September 21, 2024, Professor Thomas Seyfried presented at a BSI Medical Society event in Boston. His talk focuses on cancer as a mitochondrial metabolic disease rather than a genetic one. Seyfried challenges the mainstream somatic mutation theory, which suggests that genetic mutations drive cancer. Instead, he argues that cancer arises from chronic mitochondrial damage…

Read More

COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign

Re-analysis of the Pfizer trial data identified statistically significant increases in serious adverse events (SAEs) in the vaccine group. Numerous SAEs were identified following the Emergency Use Authorization (EUA), including death, cancer, cardiac events, and various autoimmune, hematological, reproductive, and neurological disorders. Furthermore, these products never underwent adequate safety and toxicological testing in accordance with…

Read More

Hemodilution

An increase in plasma volume relative to red blood cell mass, known as hemodilution, can lead to a seemingly lower concentration of red blood cells in the blood, even if the actual number of red blood cells remains the same.  Hemodilution refers to the dilution of blood components, particularly red blood cells, due to an increase…

Read More